Vulvodynia Study Endorsing Gabapentin for Pelvic Muscle Pain: An In-depth Look

Authors

Michelle Krichbaum, Nova Southeastern UniversityFollow
Jeffrey Fudin, Albany College of Pharmacy and Health SciencesFollow

Publication Title

Pharmacy Times

Publication Date / Copyright Date

1-9-2019

Publisher

Intellisphere

Abstract

Sexual pain in women remains a difficult and elusive medical condition to treat. Provoked vulvodynia current recommended therapies include pelvic floor physical therapy and psychological interventions including cognitive behavioral therapy (CBT) and sexual counseling.¹ Pharmacologic options remain limited to topical lidocaine, hormonal cream (typically estrogen + testosterone), and tricyclic antidepressants and their evidence for use remains mixed at best. Vulvodynia etiology is multifactorial and likely involves central sensitization, muscle and tissue nociception, and mucosal mechanoreceptor dysfunction.

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Keywords

cognitive behavioral therapy (CBT), gabapentin, pelvis, sexual counseling, vulvodynia study

NSUWorks Citation

Krichbaum, Michelle and Fudin, Jeffrey, "Vulvodynia Study Endorsing Gabapentin for Pelvic Muscle Pain: An In-depth Look" (2019). Faculty Articles. 342.
https://nsuworks.nova.edu/hpd_corx_facarticles/342